Mad Money with Jim Cramer

Jim Cramer explains why he's bullish on Eli Lilly despite its Alzheimer's drug's regulatory obstacle

Cramer explained why the regulatory obstacle facing Eli Lilly's Alzheimer's drug doesn't change his opinion of the stock.
Share
07:10
Mon, Jan 23 20237:11 PM EST